Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3680292rdf:typepubmed:Citationlld:pubmed
pubmed-article:3680292lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C0017082lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C0242209lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:3680292lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3680292pubmed:issue35lld:pubmed
pubmed-article:3680292pubmed:dateCreated1988-1-21lld:pubmed
pubmed-article:3680292pubmed:abstractTextWe have previously reported the presence of GM2 as the major ganglioside in the roe of striped mullet, Mugil cephalus, (Li, Y.-T., Hirabayashi, Y., DeGasperi, R., Yu, R. K., Ariga, T., Koerner, T. A. W., and Li, S.-C. (1984) J. Biol. Chem. 259, 8980-8985). In addition to GM2, mullet roe also contain a series of gangliosides with thin-layer chromatographic mobilities slower than GM2. Besides enzymatic hydrolysis and NMR spectroscopy, we have employed the thin-layer chromatography overlay technique using a human monoclonal IgM antibody which recognizes the GM2 epitope to study the nature of these gangliosides. Using these methods we have isolated and characterized three novel mullet roe gangliosides with the following structures: (Formula: see text). These three gangliosides all contain neolacto-series sugar chains. However, the unique feature of gangliosides 5 and 10 is that the terminal portion of the sugar chain is of the ganglio-series while the internal portion is of the neolacto series structure. Due to the substitution of a GalNAc on the internal Gal in 9 and 10 in the inner core, these two gangliosides also contain the gangliotriaosyl structure. Thus, the sugar chains in these gangliosides are of novel type and can be considered a hybrid between the two series which can be defined as the neolacto-ganglio series.lld:pubmed
pubmed-article:3680292pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:languageenglld:pubmed
pubmed-article:3680292pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:citationSubsetIMlld:pubmed
pubmed-article:3680292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3680292pubmed:statusMEDLINElld:pubmed
pubmed-article:3680292pubmed:monthDeclld:pubmed
pubmed-article:3680292pubmed:issn0021-9258lld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:LiY TYTlld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:LiS CSClld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:IshikawaYYlld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:QuarlesR HRHlld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:KoernerT ATAlld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:DeGasperiRRlld:pubmed
pubmed-article:3680292pubmed:authorpubmed-author:IlyasA AAAlld:pubmed
pubmed-article:3680292pubmed:issnTypePrintlld:pubmed
pubmed-article:3680292pubmed:day15lld:pubmed
pubmed-article:3680292pubmed:volume262lld:pubmed
pubmed-article:3680292pubmed:ownerNLMlld:pubmed
pubmed-article:3680292pubmed:authorsCompleteYlld:pubmed
pubmed-article:3680292pubmed:pagination17149-55lld:pubmed
pubmed-article:3680292pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:meshHeadingpubmed-meshheading:3680292-...lld:pubmed
pubmed-article:3680292pubmed:year1987lld:pubmed
pubmed-article:3680292pubmed:articleTitleIsolation and characterization of gangliosides with hybrid neolacto-ganglio-type sugar chains.lld:pubmed
pubmed-article:3680292pubmed:affiliationDepartment of Biochemistry, Tulane University School of Medicine, New Orleans, Louisiana 70112.lld:pubmed
pubmed-article:3680292pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3680292pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3680292pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3680292pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed